10 20 30 40 50 60 70 80 2G57 - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER ONCOPROTEIN 22-FEB-06 2G57
TITLE STRUCTURE OF THE PHOSPHORYLATION MOTIF OF THE ONCOGENIC TITLE 2 PROTEIN BETA-CATENIN RECOGNIZED BY A SELECTIVE MONOCLONAL TITLE 3 ANTIBODY
COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-CATENIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 19-44; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMANS.
KEYWDS BETA-CATENIN ONCOGENIC PROTEIN, P-BETA-CATENIN KEYWDS 2 PHOSPHORYLATED PEPTIDE, EPITOPE MAPPING, ANTIBODY, P-BETA- KEYWDS 3 CATENIN/ANTIBODY COMPLEX, STD-NMR, TRNOESY, RESTRAINED KEYWDS 4 MOLECULAR DYNAMICS, BOUND STRUCTURE, BINDING FRAGMENT, KEYWDS 5 ONCOPROTEIN
EXPDTA SOLUTION NMR
NUMMDL 10
AUTHOR S.MEGY,G.BERTHO,J.GHARBI-BENAROUS,F.BALEUX,R.BENAROUS, AUTHOR 2 J.P.GIRAULT
REVDAT 3 24-FEB-09 2G57 1 VERSN REVDAT 2 10-OCT-06 2G57 1 JRNL REVDAT 1 28-MAR-06 2G57 0
JRNL AUTH S.MEGY,G.BERTHO,J.GHARBI-BENAROUS,F.BALEUX, JRNL AUTH 2 R.BENAROUS,J.P.GIRAULT JRNL TITL STD AND TRNOESY NMR STUDIES FOR THE EPITOPE JRNL TITL 2 MAPPING OF THE PHOSPHORYLATION MOTIF OF THE JRNL TITL 3 ONCOGENIC PROTEIN BETA-CATENIN RECOGNIZED BY A JRNL TITL 4 SELECTIVE MONOCLONAL ANTIBODY JRNL REF FEBS LETT. V. 580 5411 2006 JRNL REFN ISSN 0014-5793 JRNL PMID 16996060 JRNL DOI 10.1016/J.FEBSLET.2006.08.084
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : ARIA 1.2 REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2G57 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-FEB-06. REMARK 100 THE RCSB ID CODE IS RCSB036702.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 278 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 20MM REMARK 210 PRESSURE : 1ATM REMARK 210 SAMPLE CONTENTS : 1MM P-BETA-CAT PEPTIDE WITH REMARK 210 0.01MM ANTIBODY; 20MM REMARK 210 PHOSPHATE BUFFERED SALINE(PH REMARK 210 7.4); 15MM SODIUM AZIDE; 90% REMARK 210 H2O, 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR, FELIX REMARK 210 METHOD USED : DISTANCE GEOMETRY, SIMULATED REMARK 210 ANNEALING, TORSION ANGLE REMARK 210 DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 20 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLN A 28 -18.65 -142.44 REMARK 500 2 THR A 41 38.51 -156.26 REMARK 500 2 ALA A 43 -51.00 -157.20 REMARK 500 3 GLN A 28 -31.84 -132.69 REMARK 500 3 THR A 41 32.11 -151.07 REMARK 500 3 ALA A 43 77.18 51.83 REMARK 500 4 ILE A 35 74.35 55.75 REMARK 500 4 THR A 41 34.69 -147.80 REMARK 500 4 ALA A 43 88.01 57.00 REMARK 500 5 ILE A 35 -37.77 -130.41 REMARK 500 5 ALA A 39 -8.52 71.68 REMARK 500 5 THR A 41 29.68 173.90 REMARK 500 5 THR A 42 8.98 59.21 REMARK 500 5 ALA A 43 80.30 50.08 REMARK 500 7 ALA A 43 -50.67 -171.06 REMARK 500 8 THR A 40 24.75 -147.30 REMARK 500 8 THR A 42 31.22 -142.56 REMARK 500 9 GLN A 28 -10.61 -143.57 REMARK 500 9 THR A 41 26.95 -169.53 REMARK 500 9 ALA A 43 76.02 46.99 REMARK 500 10 GLN A 28 -1.01 -144.03 REMARK 500 10 ILE A 35 97.07 68.87 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACE A 18 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NH2 A 45
DBREF 2G57 A 19 44 UNP P35222 CTNB1_HUMAN 19 44
SEQADV 2G57 SEP A 33 UNP P35222 SER 33 MODIFIED RESIDUE SEQADV 2G57 SEP A 37 UNP P35222 SER 37 MODIFIED RESIDUE
SEQRES 1 A 28 ACE LYS ALA ALA VAL SER HIS TRP GLN GLN GLN SER TYR SEQRES 2 A 28 LEU ASP SEP GLY ILE HIS SEP GLY ALA THR THR THR ALA SEQRES 3 A 28 PRO NH2
MODRES 2G57 SEP A 33 SER PHOSPHOSERINE MODRES 2G57 SEP A 37 SER PHOSPHOSERINE
HET ACE A 18 6 HET SEP A 33 14 HET SEP A 37 14 HET NH2 A 45 3
HETNAM ACE ACETYL GROUP HETNAM SEP PHOSPHOSERINE HETNAM NH2 AMINO GROUP
HETSYN SEP PHOSPHONOSERINE
FORMUL 1 ACE C2 H4 O FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 1 NH2 H2 N
LINK C ACE A 18 N LYS A 19 1555 1555 1.33 LINK C ASP A 32 N SEP A 33 1555 1555 1.33 LINK C SEP A 33 N GLY A 34 1555 1555 1.33 LINK C PRO A 44 N NH2 A 45 1555 1555 1.33 LINK C HIS A 36 N SEP A 37 1555 1555 1.33 LINK C SEP A 37 N GLY A 38 1555 1555 1.33
SITE 1 AC1 1 VAL A 22 SITE 1 AC2 1 PRO A 44
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000